MedPage Today -- In 2002 the FDA approved a product that many thought would revolutionize spinal surgery -- recombinant human bone morphogenetic protein-2, or BMP-2, which could almost magically create bone where none existed. Six years later, the FDA warned doctors that this remarkable product had the potential to cause life-threatening complications.
